BeOne Medicines AG has entered into a new Facilities Agreement with a syndicate of financial institutions, including The Hongkong and Shanghai Banking Corporation Limited acting as global coordinator, lead arranger, and agent. Under this agreement, BeOne Medicines AG and certain subsidiaries secured new financing, enabling the company to fully repay and terminate its previous credit facility with China Merchants Bank Co., Ltd., originally dated December 9, 2024. All commitments, guarantees, and security interests related to the former facility were also terminated, with no penalties incurred in connection with the repayment and closure of the prior arrangement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001651308-25-000153), on December 19, 2025, and is solely responsible for the information contained therein.
Comments